Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023 16:00 ET
|
Caribou Biosciences, Inc.
-- CB-010 ANTLER Phase 1 trial continues enrolling second-line r/r LBCL patients in dose expansion; plan to share FDA feedback by year-end 2023 and report initial dose expansion data in H1 2024 -- ...
eHealth Exchange and CRISP Shared Services Announce QHIN Intentions
August 18, 2022 09:00 ET
|
eHealth Exchange
VIENNA, Va., Aug. 18, 2022 (GLOBE NEWSWIRE) -- eHealth Exchange today announced that CRISP Shared Services, which provides health information exchange (HIE) and health data utility infrastructure...